BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33964910)

  • 41. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
    Sin DD; Leung R; Gan WQ; Man SP
    BMC Pulm Med; 2007 Oct; 7():13. PubMed ID: 17922919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.
    Ban WH; Kang HH; Kim IK; Ha JH; Joo H; Lee JM; Lim JU; Lee SH; Rhee CK
    Korean J Intern Med; 2018 Jul; 33(4):745-752. PubMed ID: 29529843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association of elevated circulating endocan levels with lung function decline in COPD patients.
    Dai L; He J; Chen J; Wang T; Liu L; Shen Y; Chen L; Wen F
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3699-3706. PubMed ID: 30519013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction.
    Fruchter O; Rosengarten D; Goldberg E; Ben-Zvi H; Tor R; Kramer MR
    Clin Respir J; 2016 Mar; 10(2):239-45. PubMed ID: 25196428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
    Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of a perioperative pulmonary rehabilitation program following coronary artery bypass graft surgery in patients with and without COPD.
    Chen JO; Liu JF; Liu YQ; Chen YM; Tu ML; Yu HR; Lin MC; Lin CC; Liu SF
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1591-1597. PubMed ID: 29805258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exacerbation frequency and course of COPD.
    Halpin DM; Decramer M; Celli B; Kesten S; Liu D; Tashkin DP
    Int J Chron Obstruct Pulmon Dis; 2012; 7():653-61. PubMed ID: 23055714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.
    Leem AY; Kim YS; Lee JH; Kim TH; Kim HY; Oh YM; Lee SD; Jung JY
    Respir Res; 2019 Dec; 20(1):279. PubMed ID: 31818285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
    Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
    Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
    Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.
    Calverley PM; Eriksson G; Jenkins CR; Anzueto AR; Make BJ; Persson A; Fagerås M; Postma DS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():13-25. PubMed ID: 28031707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteasome activity related with the daily physical activity of COPD patients.
    Lee KY; Chen TT; Chiang LL; Chuang HC; Feng PH; Liu WT; Chen KY; Ho SC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1519-1525. PubMed ID: 28579770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
    Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
    Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.